Shenzhen Chipscreen Biosciences Co (688321) — Net Asset Quality Index
Shenzhen Chipscreen Biosciences Co (688321) has a Net Asset Quality Index of 45.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.63 Billion minus total liabilities of CN¥1.98 Billion yields net assets of CN¥1.66 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Shenzhen Chipscreen Biosciences Co balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shenzhen Chipscreen Biosciences Co Net Asset Quality Index Over Time (2016–2024)
This chart shows how Shenzhen Chipscreen Biosciences Co's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at 45.6%, representing net assets of CN¥1.66 Billion against total assets of CN¥3.63 Billion CNY. For live market cap and overall valuation, see 688321 market cap.
Annual Net Asset Quality Index for Shenzhen Chipscreen Biosciences Co (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Shenzhen Chipscreen Biosciences Co from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 688321 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 48.6% | CN¥1.58 Billion | CN¥3.25 Billion | CN¥1.67 Billion | ▼ -4.7 pp |
| 2023 | 53.4% | CN¥1.71 Billion | CN¥3.20 Billion | CN¥1.49 Billion | ▼ -1.0 pp |
| 2022 | 54.4% | CN¥1.58 Billion | CN¥2.90 Billion | CN¥1.32 Billion | ▼ -20.4 pp |
| 2021 | 74.8% | CN¥1.42 Billion | CN¥1.89 Billion | CN¥476.79 Million | ▼ -11.7 pp |
| 2020 | 86.5% | CN¥1.49 Billion | CN¥1.73 Billion | CN¥232.44 Million | ▲ +1.0 pp |
| 2019 | 85.5% | CN¥1.45 Billion | CN¥1.69 Billion | CN¥245.10 Million | ▲ +18.9 pp |
| 2018 | 66.6% | CN¥476.90 Million | CN¥716.34 Million | CN¥239.44 Million | ▼ -2.1 pp |
| 2017 | 68.7% | CN¥450.55 Million | CN¥656.02 Million | CN¥205.47 Million | ▲ +15.7 pp |
| 2016 | 52.9% | CN¥213.40 Million | CN¥403.13 Million | CN¥189.73 Million | — |